Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)

China flag China · Delayed Price · Currency is CNY
11.47
-0.05 (-0.43%)
Apr 29, 2026, 3:00 PM CST
28.73%
Market Cap 13.32B
Revenue (ttm) 10.31B
Net Income (ttm) 702.17M
Shares Out 1.16B
EPS (ttm) 0.60
PE Ratio 19.22
Forward PE 25.21
Dividend 0.21 (1.82%)
Ex-Dividend Date n/a
Volume 33,234,525
Average Volume 32,400,070
Open 11.44
Previous Close 11.52
Day's Range 11.16 - 11.65
52-Week Range 8.66 - 13.06
Beta 0.38
RSI 61.69
Earnings Date Apr 8, 2026

About SHA:600267

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small molecule, animal healthcare, and others. The company exports its products to approximately 70 countries worldwide. Zhejiang Hisun Pharmaceutical Co., Ltd.... [Read more]

Sector Healthcare
Founded 1956
Employees 7,994
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600267
Full Company Profile

Financial Performance

In 2025, SHA:600267's revenue was 10.55 billion, an increase of 2.03% compared to the previous year's 10.34 billion. Earnings were 540.71 million, a decrease of -10.06%.

Financial Statements

News

There is no news available yet.